LGALS9 and breast carcinoma: With respect to the stratified analysis by cancer type, no significant association was evident between Gal-9 expression and DFS/RFS for breast cancer (pooled HR = 0.69, 95% CI = 0.08–5.75, P = 0.733) or urinary tumors (pooled HR = 1.13, 95% CI = 0.34–3.72, P = 0.84).